How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

FDA's new genome editing guidance: Why patient identification matters earlier in development

calendar_today November 3, 2026 person Lisa Conroy, MPH domain sano

The FDA’s draft guidance on individualized human genome editing products , issued on 27 October 2026, proposes a pathway that could allow a single biologics license application (BLA) to cover multiple patient-specific versions of a genome editing product.

open_in_new Read original post